Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (661-670 of 671) with videos related to

Pageof 68
Sort By:
Blood Cancer Discovery|May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Cell|September 30, 2022
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host diseaseEiko Hayase, Tomo Hayase, Mohamed A Jamal, et al.
Transplantation and Cellular Therapy|July 19, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2021
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30<sup>+</sup> MalignanciesLucila N Kerbauy, Nancy D Marin, Mecit Kaplan, et al.
Research Square|February 13, 2023
<i>Bacteroides ovatus</i> alleviates dysbiotic microbiota-induced intestinal graft-versus-host diseaseEiko Hayase, Tomo Hayase, Akash Mukherjee, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
The Journal of Clinical Investigation|June 17, 2021
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cellsHila Shaim, Mayra Shanley, Rafet Basar, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Cell Host & Microbe|August 30, 2024
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host diseaseEiko Hayase, Tomo Hayase, Akash Mukherjee, et al.
Pageof 68

Showing results (661-670 of 671) with videos related to

Sort By:
Pageof 68
Blood Cancer Discovery|May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Cell|September 30, 2022
Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host diseaseEiko Hayase, Tomo Hayase, Mohamed A Jamal, et al.
Transplantation and Cellular Therapy|July 19, 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD ProphylaxisRima M Saliba, Amin M Alousi, Joseph Pidala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2021
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30<sup>+</sup> MalignanciesLucila N Kerbauy, Nancy D Marin, Mecit Kaplan, et al.
Research Square|February 13, 2023
<i>Bacteroides ovatus</i> alleviates dysbiotic microbiota-induced intestinal graft-versus-host diseaseEiko Hayase, Tomo Hayase, Akash Mukherjee, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
The Journal of Clinical Investigation|June 17, 2021
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cellsHila Shaim, Mayra Shanley, Rafet Basar, et al.
Blood|September 9, 2020
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cellsMay Daher, Rafet Basar, Elif Gokdemir, et al.
Cell Host & Microbe|August 30, 2024
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host diseaseEiko Hayase, Tomo Hayase, Akash Mukherjee, et al.
Pageof 68